Supporting this, the gene LGALS2, which encodes Galectin-2, has been linked to greater infiltration of TIM-3+ CTLs within the tumor microenvironment, suggesting a more extensive role of galectin in modulating TIM-3 signaling [150]. The gene discussed is HAVCR2; the disease is neoplasm.